Brendan W. Corey

1.6k total citations · 1 hit paper
18 papers, 591 citations indexed

About

Brendan W. Corey is a scholar working on Molecular Medicine, Molecular Biology and Endocrinology. According to data from OpenAlex, Brendan W. Corey has authored 18 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Medicine, 6 papers in Molecular Biology and 6 papers in Endocrinology. Recurrent topics in Brendan W. Corey's work include Antibiotic Resistance in Bacteria (13 papers), Bacteriophages and microbial interactions (4 papers) and Enterobacteriaceae and Cronobacter Research (2 papers). Brendan W. Corey is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Bacteriophages and microbial interactions (4 papers) and Enterobacteriaceae and Cronobacter Research (2 papers). Brendan W. Corey collaborates with scholars based in United States and Thailand. Brendan W. Corey's co-authors include Daniel V. Zurawski, Mitchell G. Thompson, Anna C. Jacobs, David W. Craft, Yuanzheng Si, Patrick McGann, François Lebreton, Biswajit Biswas, Ulrike MacDonald and Nimfa Teneza-Mora and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Brendan W. Corey

18 papers receiving 580 citations

Hit Papers

Differentiation of hypervirulent and classical Klebsiella... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brendan W. Corey United States 12 335 192 179 125 116 18 591
Jin-Town Wang Taiwan 12 454 1.4× 223 1.2× 249 1.4× 138 1.1× 120 1.0× 14 763
Lucia Henrici De Angelis Italy 14 451 1.3× 136 0.7× 157 0.9× 147 1.2× 57 0.5× 22 605
Wensi S. Hu Taiwan 12 183 0.5× 96 0.5× 173 1.0× 111 0.9× 78 0.7× 26 482
Shiva Mirkalantari Iran 11 191 0.6× 110 0.6× 168 0.9× 92 0.7× 100 0.9× 31 465
José Luis Insua United Kingdom 8 353 1.1× 78 0.4× 192 1.1× 158 1.3× 81 0.7× 10 627
Ronan A. Murphy United Kingdom 9 213 0.6× 84 0.4× 215 1.2× 165 1.3× 84 0.7× 17 550
Supeng Yin China 15 169 0.5× 214 1.1× 236 1.3× 73 0.6× 98 0.8× 26 520
Etthel M. Windels Belgium 9 372 1.1× 100 0.5× 396 2.2× 161 1.3× 56 0.5× 13 857
Jean-Guillaume Emond-Rhéault Canada 12 253 0.8× 156 0.8× 395 2.2× 155 1.2× 69 0.6× 22 640
Yongchang Xu China 16 512 1.5× 80 0.4× 185 1.0× 155 1.2× 42 0.4× 37 737

Countries citing papers authored by Brendan W. Corey

Since Specialization
Citations

This map shows the geographic impact of Brendan W. Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brendan W. Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brendan W. Corey more than expected).

Fields of papers citing papers by Brendan W. Corey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brendan W. Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brendan W. Corey. The network helps show where Brendan W. Corey may publish in the future.

Co-authorship network of co-authors of Brendan W. Corey

This figure shows the co-authorship network connecting the top 25 collaborators of Brendan W. Corey. A scholar is included among the top collaborators of Brendan W. Corey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brendan W. Corey. Brendan W. Corey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Vereecke, Nick, et al.. (2025). An open-source nanopore-only sequencing workflow for analysis of clonal outbreaks delivers short-read level accuracy. Journal of Clinical Microbiology. 63(8). e0066425–e0066425. 2 indexed citations
2.
Russo, Thomas A., Ulrike MacDonald, Alan D. Hutson, et al.. (2024). Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance. mBio. 15(2). e0286723–e0286723. 52 indexed citations breakdown →
3.
Mills, Emma G., Melissa J. Martin, Ana Ong, et al.. (2022). A one-year genomic investigation of Escherichia coli epidemiology and nosocomial spread at a large US healthcare network. Genome Medicine. 14(1). 147–147. 23 indexed citations
4.
Corey, Brendan W., Erik Snesrud, Alina Iovleva, et al.. (2022). IS26-mediated plasmid reshuffling results in convergence of toxin–antitoxin systems but loss of resistance genes in XDR Klebsiella pneumoniae from a chronic infection. Microbial Genomics. 8(9). 4 indexed citations
5.
Lesho, Emil, Brendan W. Corey, François Lebreton, et al.. (2021). Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York. Clinical Infectious Diseases. 74(5). 909–912. 3 indexed citations
6.
Corey, Brendan W., et al.. (2021). First Report: Colistin Resistance Gene mcr-3.1 in Salmonella enterica Serotype Choleraesuis Isolated from Human Blood Sample from Thailand. Microbial Drug Resistance. 28(1). 102–105. 4 indexed citations
7.
Corey, Brendan W., Yunxiu He, Mikeljon P. Nikolich, et al.. (2021). Synergistic Killing and Re-Sensitization of Pseudomonas aeruginosa to Antibiotics by Phage-Antibiotic Combination Treatment. Pharmaceuticals. 14(3). 184–184. 59 indexed citations
9.
Lebreton, François, Brendan W. Corey, Christi L. McElheny, et al.. (2021). Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri. Antimicrobial Agents and Chemotherapy. 65(7). e0015021–e0015021. 15 indexed citations
10.
Warkentien, Tyler, et al.. (2020). Bacteroides Fragilis Vertebral Osteomyelitis and Discitis: "Back" to Susceptibility Testing.. PubMed. 37(5). 242–246. 3 indexed citations
11.
Galac, Madeline R., et al.. (2019). Transcriptional Regulation of icaADBC by both IcaR and TcaR in Staphylococcus epidermidis. Journal of Bacteriology. 201(6). 25 indexed citations
12.
Snesrud, Erik, Ana Ong, Brendan W. Corey, et al.. (2017). Analysis of Serial Isolates of mcr-1 -Positive Escherichia coli Reveals a Highly Active IS Apl1 Transposon. Antimicrobial Agents and Chemotherapy. 61(5). 56 indexed citations
13.
Regeimbal, James, Anna C. Jacobs, Brendan W. Corey, et al.. (2016). Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections. Antimicrobial Agents and Chemotherapy. 60(10). 5806–5816. 142 indexed citations
14.
Corey, Brendan W., Anna C. Jacobs, Roberta J. Melander, et al.. (2016). 1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumannii. ACS Medicinal Chemistry Letters. 8(1). 27–31. 19 indexed citations
15.
Corey, Brendan W., Mitchell G. Thompson, Lauren Hittle, et al.. (2016). 1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial Pathogens. ACS Infectious Diseases. 3(1). 62–71. 11 indexed citations
16.
Jacobs, Anna C., Mitchell G. Thompson, Michael J. Gebhardt, et al.. (2014). Genetic Manipulation of Acinetobacter baumannii. Current Protocols in Microbiology. 35(1). 6G.2.1–11. 19 indexed citations
17.
Corey, Brendan W., et al.. (2012). A Computational Model for the Facilitated Transport of Metronidazole by Iontophoresis. eCommons (Cornell University). 1 indexed citations
18.
Thompson, Mitchell G., Brendan W. Corey, Yuanzheng Si, David W. Craft, & Daniel V. Zurawski. (2012). Antibacterial Activities of Iron Chelators against Common Nosocomial Pathogens. Antimicrobial Agents and Chemotherapy. 56(10). 5419–5421. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026